Bob, you are right of course, but it is hard to really see SOL as a diversified investment house with a history of 'steady as she goes', suddenly take on the qualities that drove CSL as a highly focused leading niche operator in the market of plasma and blood products.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)